(Press-News.org) Scientists have for the first time provided proof of principle for a drug-based treatment of acute pancreatitis – a disease which is often alcohol-related and for which currently there is no treatment.
Each year around 20,000 people in the UK are admitted to hospital with acute pancreatitis. One in five of these cases are severe, resulting in around 1000 deaths annually.
Published in the US-based PNAS journal*, findings reveal that tests undertaken by scientists at Cardiff University, using an existing calcium channel-blocking compound developed by GlaxoSmithKline, have succeeded in markedly reducing the flow of calcium into isolated pancreatic cells and stopping the root cause of the disease in its tracks.
"The aim of the research was to block excessive calcium entry caused by agents inducing pancreatitis and then test whether this would protect the pancreatic cells from self-digestion and death," explains Senior Author of the research and Director of Cardiff University's School of Biosciences, MRC Professor Ole Petersen FRS.
"Our research shows that the calcium channel inhibiting compound offers unique and effective protection against inappropriate activation inside the cells of digestive enzymes, which would cannibalise the pancreas and the surrounding tissue.
"This breakthrough shows huge potential to radically change and improve the outcome for patients suffering from severe pancreatitis. The publication of these findings will open the way for further research involving animals and humans – and, if successful, we shall for the first time be able to treat this often fatal disease."
The research was funded by a £2.3M Medical Research Council (MRC) Programme grant.
Dr Joe McNamara, Population and Systems Medicine Board Chair at the Medical Research Council who funded the study, said: "While further research will be needed to show that the success seen here in cells can be replicated in animal and then human trials, this is clearly an interesting study which takes an innovative first step towards drug development for acute pancreatitis, an increasingly common condition for which new treatment options are sorely needed."
Repeated attacks of acute pancreatitis can lead to chronic pancreatitis, which manifestly increases the risk of developing pancreatic cancer; currently one of the top four cancer killers in the UK. A treatment driven by this compound may also reduce the risk of patients developing pancreatic cancer.
Previous research by Professor Petersen and his team has determined that processes inside isolated pancreatic cells leading to pancreatitis can be induced by the combination of alcohol and fat.
When alcohol and fatty acids mix inside the pancreas, a massive release of calcium stored inside the pancreatic cells is triggered. The emptying of these calcium stores then sets in motion the opening of special channels in the cell membrane that allow calcium to enter the cells.
The intrusion of this calcium causes activation of normally inactive digestive enzymes inside the cells, which in turn start digesting the pancreas and everything around it.
###
The paper, entitled "Calcium release-activated calcium channel blockade as a potential tool in anti-pancreatitis therapy" is published here.
A briefing on the paper has also been published in the Nature Group journal 'Science-Business eXchange', which can be accessed here.
*Proceedings of the National Academy of Sciences USA
Medical Research Council (MRC)
Cardiff University School of Biosciences
For further information or to arrange an interview, please contact:
Professor Ole Petersen CBE FRS
E-mail: director-biosi@cardiff.ac.uk
Telephone:+44 (0)29 208 74120
Tomas Llewelyn Barrett
Public Relations
Cardiff University
Tel: 029 20 875 596
Mobile: 07950792532
E-mail: BarrettTL1@cardiff.ac.uk
Cardiff University
Cardiff University is recognised in independent government assessments as one of Britain's leading teaching and research universities and is a member of the Russell Group of the UK's most research intensive universities. Among its academic staff are two Nobel Laureates, including the winner of the 2007 Nobel Prize for Medicine, University Chancellor Professor Sir Martin Evans. Founded by Royal Charter in 1883, today the University combines impressive modern facilities and a dynamic approach to teaching and research. The University's breadth of expertise encompasses: the College of Humanities and Social Sciences; the College of Biomedical and Life Sciences; and the College of Physical Sciences, along with a longstanding commitment to lifelong learning. Cardiff's three flagship Research Institutes are offering radical new approaches to neurosciences and mental health, cancer stem cells and sustainable places.
Scientists edge closer towards first pancreatitis treatment
2013-09-03
ELSE PRESS RELEASES FROM THIS DATE:
National Sleep Foundation 2013 Bedroom Poll explores sleep differences among 6 countries
2013-09-03
Washington, DC -- September 3, 2013 -- The National Sleep Foundation (NSF) released its first international poll today, the 2013 International Bedroom Poll, comparing sleep times, attitudes, habits and bedtime routines of those in the United States, Canada, Mexico, the United Kingdom, Germany and Japan between the ages of 25 and 55 years old.
Japan and the United States report the least amount of sleep.
Japanese and Americans report sleeping about 30 to 40 minutes less on workdays than those in the other countries surveyed, averaging 6 hours and 22 minutes and 6 hours ...
Death by asexuality: IU biologists uncover new path for mutations to arise
2013-09-03
BLOOMINGTON, Ind. -- Ground-breaking new research from a team of evolutionary biologists at Indiana University shows for the first time how asexual lineages of a species are doomed not necessarily from a long, slow accumulation of new mutations, but rather from fast-paced gene conversion processes that simply unmask pre-existing deleterious recessive mutations.
Geneticists have long bet on the success of sexual reproduction over asexual reproduction based in a large part on the process known as Muller's ratchet, the mechanism by which a genome accrues deleterious and ...
Atom-based analogues to electronic devices
2013-09-03
Scientists have pushed back the boundaries of atom-based transport, creating a current by characterizing the many-body effects in the transport of the atoms along a periodic lattice. This work by Anton Ivanov and colleagues from the Institute for Theoretical Physics, at the University of Heidel-berg, Germany, adopted a new analytical approach before comparing it to approximate numerical simulations, and is reported in a paper recently published in EPJ B.
Ultra-cold atoms trapped in optical potentials offer solutions for the transport of particles capable of producing ...
Scientists discover new bat species in West Africa
2013-09-03
An international team of scientists, including biologists from, the University of York, has discovered five new species of bats in West Africa.
The team, which also included researchers from the Czech University of Life Sciences and the Academy of Sciences, Charles University in the Czech Republic, discovered a wealth of unexpected diversity among Vesper bats in Senegal.
During seven expeditions to the Niokolo-Koba National Park in south-eastern Senegal, and subsequent genetic analysis, the scientists discovered that five species of bats looked similar to other populations ...
New evidence to aid search for charge 'stripes' in superconductors
2013-09-03
UPTON, NY - Scientists at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory have identified a series of clues that particular arrangements of electrical charges known as "stripes" may play a role in superconductivity-the ability of some materials to carry electric current with no energy loss. But uncovering the detailed relationship between these stripe patterns and the appearance or disappearance of superconductivity is extremely difficult, particularly because the stripes that may accompany superconductivity are very likely moving, or fluctuating.
As ...
Researchers propose a new system for quantum simulation
2013-09-03
Researchers from the universities in Mainz, Frankfurt, Hamburg and Ulm have proposed a new platform for quantum simulation. In a theoretical paper recently published in Physical Review Letters, they show that a combined system of ultracold trapped ions and fermionic atoms could be used to emulate solid state physics. This system may outperform possibilities of existing platforms as a number of phenomena found in solid state systems are naturally included, such as the fermionic statistics of the electrons and the electron-sound wave interactions.
Quantum simulation was ...
Ground breaking research identifies promising drugs for treating Parkinson's
2013-09-03
New drugs which may have the potential to stop faulty brain cells dying and slow down the progression of Parkinson's, have been identified by scientists in a pioneering study which is the first of its kind.
Experts from the world leading Sheffield Institute for Translational Neuroscience (SITraN) conducted a large scale drugs trial in the lab using skin cells from people with this progressive neurological condition which affects one in every 500 people in the UK.
The researchers tested over 2,000 compounds to find out which ones could make faulty mitochondria work ...
Nursing students lack effective role models for infection prevention: Study
2013-09-03
Washington, DC, September 3, 2013 – 100 percent of student nurses surveyed observed lapses in infection prevention and control practices during their clinical placements, according to a British study published in the September issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
Infection prevention and control (IPC) education is a fundamental component of the nursing curriculum, but little is understood about nursing students' experience of IPC in the clinical setting ...
Can you predict complications with back surgery? Preoperative factors increase risk
2013-09-03
Philadelphia, Pa. (September 1, 2013) - For older adults undergoing surgery for spinal stenosis, some simple indicators of poor preoperative health predict a high risk of major medical complications, reports a study in the September 1 issue of Spine. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
In combination, these risk factors may help in identifying patients at increased risk of heart attack and other serious events after spinal stenosis surgery, according to the report by Dr Richard A. Deyo and colleagues of Oregon ...
Cleveland Clinic research finds no benefit over placebo in ASSURE trial
2013-09-03
Monday, Sept. 3, 2013, Cleveland: Patients with coronary artery disease and low levels of "good cholesterol – or high-density lipoprotein (HDL) – who were treated with a drug designed to increase HDL levels and reduce coronary plaque build-up, experienced no better results than those treated with placebo, according to research conducted by the Cleveland Clinic Coordinating Center for Clinical Research (C5Research).
The drug, RVX-208, induces the production of apolipoprotein A1 (apoA1), a major protein in HDL. Prior research has shown that higher levels of HDL are associated ...